Life Sciences
The results will not impact the current rollout of a new version of the app, under special FDA guidelines.
It's been quite a year for digital, from Akili's de novo clearance to the downfall of 'digital pill' maker Proteus. MobiHealthNews takes a look back at the highlights.
At a recent online event, Novartis Chief Digital Officer Betrand Bodson gave an update on a digital strategy that began in 2018.
The pharma giant is collaborating with sports tech firm Supersapiens.
The paper discusses the potenital for collecting real-world data, recruiting patients and using APIs.
Major pharmacies and services say they're unaffected by USPS troubles so far, but some online platforms that rely on the service are worried about their patients and long-term business.
The AI-enabled company works with pharma companies and research institutions on research and development for new medications.
The companies will also be looking into using Eko's tech in clinical trials.
The original focus will be on multiple sclerosis but will extend to include Huntington's disease and hemophilia.
The connected inhaler's launch will be followed by Teva's other Digihaler products before the end of the year.